We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK TO PROVIDE FLU VACCINE UNDER IND APPLICATION
GSK TO PROVIDE FLU VACCINE UNDER IND APPLICATION
December 10, 2004
GlaxoSmithKline (GSK) will sell 1.2 million doses of its influenza vaccine, Fluarix, to HHS after the FDA authorized the importation of the product into the U.S. under an investigational new drug application (IND).